PROMEDIUS Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $14.3M

  • Investors
  • 25

PROMEDIUS General Information

Description

Developer of an artificial intelligence imaging platform designed to screen for osteoporosis and support fracture prevention. The company offers chest X-ray-based osteoporosis detection technology powered by artificial intelligence, enabling healthcare providers to identify osteoporosis earlier and support healthy ageing outcomes.

Contact Information

Website
www.promedius.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 13, Olympic-ro 35da-gil
  • Songpa-gu
  • Seoul, 05510
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 13, Olympic-ro 35da-gil
  • Songpa-gu
  • Seoul, 05510
  • South Korea
+82

PROMEDIUS Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PROMEDIUS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 05-Jun-2026 $14.3M Completed Generating Revenue
9. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Accelerator/Incubator Completed Generating Revenue
6. Later Stage VC (Series A2) 10-Mar-2024 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
4. Early Stage VC (Series A) 21-Oct-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Sep-2020 Completed Startup
2. Seed Round 30-Jun-2020 Completed Startup
1. Spin-Off 01-Sep-2019 Completed Startup
To view PROMEDIUS’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

PROMEDIUS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence imaging platform designed to screen for osteoporosis and support fracture preven
Decision/Risk Analysis
Seoul, South Korea
40 As of 2026

Geneva, Switzerland
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PROMEDIUS Competitors (2)

One of PROMEDIUS’s 2 competitors is Medimaps Group, a Venture Capital-Backed company based in Geneva, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Medimaps Group Venture Capital-Backed Geneva, Switzerland
16 Bit Accelerator/Incubator Backed Toronto, Canada
You’re viewing 2 of 2 competitors. Get the full list »

PROMEDIUS Patents

  • 26

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

PROMEDIUS Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026197518-A1 Method for determining bone disease by using artificial intelligence model and electronic device therefor Pending 20-Mar-2025
EP-4837509-A1 Apparatus and method for measuring muscle for each part and detecting vertebral segment in medical image Pending 07-Mar-2025
EP-4797281-A1 System and method for diagnosing osteopenia by using x-ray images Pending 26-Sep-2024
WO-2026071677-A1 System and method for diagnosing osteopenia by using x-ray images Pending 26-Sep-2024
EP-4796042-A1 Osteoporosis diagnosis system and interpretation method using x-ray images Pending 19-Apr-2024 G06T7/0012
To view PROMEDIUS’s complete patent history, request access »

PROMEDIUS Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PROMEDIUS Investors (25)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daewoong Pharmaceutical Corporation Minority
Heungkuk Securities Corporation Minority
Industrial Bank of Korea PE/Buyout Minority
Kolon Investment Venture Capital Minority
Naver Corporation Minority
You’re viewing 5 of 25 investors. Get the full list »

Ready to get started?

Request a free trial

PROMEDIUS FAQs

  • When was PROMEDIUS founded?

    PROMEDIUS was founded in 2019.

  • Where is PROMEDIUS headquartered?

    PROMEDIUS is headquartered in Seoul, South Korea.

  • What is the size of PROMEDIUS?

    PROMEDIUS has 40 total employees.

  • What industry is PROMEDIUS in?

    PROMEDIUS’s primary industry is Decision/Risk Analysis.

  • Is PROMEDIUS a private or public company?

    PROMEDIUS is a Private company.

  • What is PROMEDIUS’s current revenue?

    The current revenue for PROMEDIUS is .

  • How much funding has PROMEDIUS raised over time?

    PROMEDIUS has raised $25M.

  • Who are PROMEDIUS’s investors?

    Daewoong Pharmaceutical, Heungkuk Securities, Industrial Bank of Korea, Kolon Investment, and Naver are 5 of 25 investors who have invested in PROMEDIUS.

  • Who are PROMEDIUS’s competitors?

    Medimaps Group and 16 Bit are competitors of PROMEDIUS.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process